Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIDENT: Triple Pill for Prevention of Recurrent Stroke in ICH Patients
NCT02699645Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- Sep 2017
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of telmisartan, amlodipine, indapamide in intracerebral hemorrhage (ICH), hypertension (HTN), sponsored by The George Institute for Global Health. Started Sep 2017; status: completed.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
intracerebral hemorrhage (ICH)hypertension (HTN)
Beyond the preview
Go deeper on NCT02699645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02699645.